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Introduction: Soft tissue sarcomas originating from the chest wall
include in their definition those originating from the trunk and, in
many cases, are analyzed together with retroperitoneal tumors
whose clinical results differ, with only a few detailed reports on such
tumors strictly limited to the chest wall available. The main purpose
of this study was to evaluate the clinical outcomes for patients with
chest wall soft tissue sarcomas.
Methods: A retrospective review of 44 surgically treated patients
was conducted from 1992 to 2006. The median age of the patients
was 51.8 years. The median follow-up time was 56.7 months. Twenty-
two sarcomas (50.0%) were high-grade, and 22 (50.0%) were
low-grade. Of the 44 patients, 31 (70.1%) had previously undergone
unplanned excision elsewhere. Histologic examinations of the sur-
gical margins, and oncological outcome for each patient were
collected and analyzed.
Results: Twenty-six (59.1%) patients were continuously free of
disease, 12 were alive and currently free of disease, three were alive
with metastasis, and three had died. Local recurrence developed in
five patients. The overall survival rate at 5 years was 88.5%. Local
recurrence-free survival rate at 5 years was 88.5%. Univariate
analyses disclosed age (p  0.05), high-grade malignancy (p 
0.05), and local recurrence (p  0.05) as independent predictors of
death. Histopathologic examination of the specimens showed that
two patients had evidence of bone invasion.
Conclusions: The clinical behavior of the chest wall soft tissue
sarcomas is similar to that of extremity sarcomas. High-grade
tumors are more likely to require a muscle transfer, and it is often
very difficult to achieve local control of them in view of their
anatomic characteristics. Considering the high local control rate in
this study, they are best controlled by adequate wide surgical
resection.
Key Words: Chest wall, Soft tissue sarcoma, Wide resection,
Clinical outcome.
(J Thorac Oncol. 2009;4: 834–837)
Primary soft tissue sarcomas of the chest wall are uncom-mon. Because of the limited experience accumulated by
single institutions with this neoplasm, there are few series of
patients described in the literature.
Soft tissue sarcomas originating from the chest wall
include in their definition those originating from the trunk
and, in many cases, are analyzed together with retroperitoneal
tumors whose clinical results differ1–3 with only a few de-
tailed reports on such tumors strictly limited to the chest wall
available. Also, their anatomic characteristics sometimes
cause particular difficulties in their treatment.
In this study, we investigated the therapeutic results of
these tumors, and we also discussed therapeutic strategies and
associated problems.
PATIENTS AND METHODS
A retrospective review of 44 patients treated for soft
tissue sarcomas originating from the chest wall was con-
ducted by our oncology group from 1992 to 2006. The
clinical results were determined, and the pathologic features
were evaluated. Computed tomography (CT) scans and mag-
netic resonance images of the chest and the site of primary
tumor were routinely obtained. The maximum tumor di-
ameter was measured on CT scans taken at the time of
diagnosis. The follow-up duration was defined from the date
of diagnosis to the date of death or the last visit. Patients were
followed for at least every 6 months in our outpatient clinic
for 10 years postsurgery or until death. Follow-up examina-
tion included evaluation of local recurrence and pulmonary
metastasis, chest CT, and magnetic resonance imaging
(MRI). One pathologist assessed the resected specimens for
tumor infiltration of bone (ribs, scapula, and sternum), tumor
grade, and microscopic margin.
We define osteosarcoma, Ewing sarcoma, rhabdomyo-
sarcoma, and synovial sarcoma to be absolute indications for
neoadjuvant chemotherapy, and malignant fibrous histiocy-
toma (MFH), liposarcoma, and malignant peripheral nerve
sheath tumor to be relative indications in high-grade cases
based on factors such as tumor size and site. The surgical
margin is planned to be more than 3 cm wide for all soft
tissue sarcomas. The indications for thoracotomy including
rib or sternum resection were sarcomas located adjacent to
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the bone, with no intervening normal tissue on MRI and
infiltration by the tumor suspected. We use a myocutaneous
flap transfer when it is difficult to cover a bone defect or
exposed bone. We usually reconstructed the chest wall with
polypropylene mesh (Marlex mesh) for defects of more than
three ribs. Radical and wide margins were considered ade-
quate, whereas marginal and intralesional margins were con-
sidered inadequate. Patients with inadequate surgical margins
received postoperative radiotherapy.
Statistics
The SPSS 11.0 program for Windows was used for
statistical analysis. The Kaplan-Meier and log-rank methods
were used to draw and evaluate the significance of event-free
survival curves. Differences were considered statistically sig-
nificant when the p value was less than 0.05.
RESULTS
There were 28 men and 16 women ranging in age from
14 to 78 years (mean 52), and the observation period was 3 to
180 months (mean 57). The site of origin was the anterior
chest in 25 cases, back in 11, and lateral chest in eight. The
maximum tumor diameter measured 1 to 25 cm (mean 7).
The pathology diagnosis was MFH in 12 cases, dermatofi-
brosarcoma protuberance in 12, liposarcoma in nine, synovial
sarcoma in two, fibrosarcoma in two, Ewing/primitive neu-
roectodermal tumor sarcoma in two, extraskeletal osteosar-
coma in two, malignant peripheral nerve sheath tumor in two,
and leiomyosarcoma in one. Twenty-two cases (50%) had
high-grade malignant tumors and 22 (50%) low-grade malig-
nant ones. The most common presenting symptom was chest
wall mass without pain in 36 patients (81.8%). Four cases
(9.1%) received chemotherapy and 4 (9.1%) postoperative
radiotherapy. Flap transfer was required in 20 cases (45%)
consisting of latissimus dorsi pedicle flaps in eight cases,
rectus abdominis pedicle flaps in two, free lateral thigh flaps
in four, free rectus abdominis flaps in two, free latissimus
dorsi flap in one, and local flaps in three (Table 1). In eight
cases (18%), thoracotomy including rib or sternum resection
was required. In 31 cases (70%), unplanned excision had
been performed by the previous treating physicians (multiple
resections in four cases and recurrence in 10 cases).
Postoperative pathologic evaluation of the resection
margin revealed a wide margin in 38 cases, marginal margin
in six, and intralesional margin in one. At the final follow-up,
the results were as follows: patients continuously free of
disease in 26 cases, patients alive with disease in three,
patients alive with currently no evidence of disease in 12, and
patients dead of disease in three. One-year and 5-year overall
survival rates were 95.1% and 88.5%, respectively. His-
topathologically, tumor infiltration of bone (ribs, scapula, and
sternum) was noted in two cases (4.5%), both of which were
recurrent cases. Local recurrence was found in five cases
(11%). One-year and 5-year local recurrence-free survival
rates were 93.2% and 88.5%, respectively. In four of the 12
MFH cases (33%), local recurrence developed despite the
acquisition of an adequate resection margin. Factors signifi-
cantly affecting life prognosis were age (p  0.05), high-
grade malignancy (p 0.05), and local recurrence (p 0.05;
Figures 1A, B). Gender, tumor location, tumor size, un-
planned excision, and surgical margin were not found to be
significant (Table 2).
DISCUSSION
The chest wall is not a clearly defined anatomic site of
origin, and numerous investigators use the definition of
“trunk” when analyzing their data on tumors in this region
and include the results of deeply situated retroperitoneal
tumors, despite the fact that these have clearly different
clinical results.1–3 Furthermore, even in studies limited to
tumors originating from the chest wall, very often primary
bone tumors and metastatic tumors to the chest wall are
included and confuse the analysis,4–8 whereas very few
reports focusing exclusively on soft tissue tumors originating
from the chest wall alone are available.9–12 Most soft tissue
sarcomas originating from the chest wall are superficial, and
even when highly malignant, their prognosis is favorable, as
compared with retroperitoneal tumors, being similar to that of
TABLE 1. Clinicopathologic Data in the 44 Patients with
Soft Tissue Sarcomas of the Chest Wall
Characteristic
No. of Patients
(n  44) Percent
Gender
Male 28 64
Female 16 36
Histological diagnosis
Malignant fibrous
histiocytoma
12 27
Dermatofibrosarcoma
protuberance
12 27
Liposarcoma 9 20
Synovial sarcoma 2 5
Fibrosarcoma 2 5
Malignant peripheral nerve
sheath tumor
2 5
Extraskeletal osteosarcoma 2 5
Ewing sarcoma 2 5
Leiomyosarcoma 1 2
Tumor localization
Anterior 25 57
Posterior 11 25
Lateral 8 18
Tumor grade
Low grade 22 50
High grade 22 50
Adjuvant chemotherapy 4 9
Postoperative radiation 4 9
Flap transfer 20 45
Latissimus dorsi flap pedicle 8
Latissimus dorsi flap free 1
Rectus abdominis flap
pedicle
2
Rectus abdominis flap free 2
Lateral thigh flap free 4
Local flap 3
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soft tissue sarcomas of the lower extremities. In this study as
well, comparable results were obtained, attributable to the
influence of local control on outcome.
Reflecting the distinctive limitations of studies on rare
cancers, this investigation was retrospective in nature, lacked
a control group, and focused on a very heterogeneous group
of lesions comprising both high-grade and low-grade malig-
nancies. However, as an analysis of soft tissue sarcomas
limited to the chest wall it is a large study and it is of
significance in investigating the anatomic characteristics of
this site.
The chest wall is a site of predilection for various
benign lesions including atheroma and lipoma. Most of these
are superficially located, facilitating resection. For this rea-
son, inappropriate resection is frequently resorted to without
input from diagnostic imaging.
In cases of low-grade malignancy, the tumor tends to
infiltrate limitedly, and appropriate additional wide resection
or wide resection of recurrences can provide good local
control as well as a favorable life prognosis. Conversely, the
development of high-grade malignant tumors such as MFH is
not rare either, and cases are occasionally encountered in
which repeated recurrences make treatment very difficult.
Some of the relevant anatomic characteristics of the
chest wall are listed below. (1) Soft tissue sarcomas originat-
ing from the chest wall are superficial and are easily palpable
on the body surface, and thus lend themselves to unplanned
excision by inexperienced physicians (Figure 2A). (2) Unlike
the upper and lower extremities, even when deeply situated,
there is no concept of compartment, with the tumor readily
infiltrating the intramuscular and subcutaneous layers (Figure
2B). (3) Primary tumors rarely infiltrate the ribs or other
bones, whereas in recurrent cases, even in the absence of
infiltration, the tumor extends close to the bone in many cases
precluding the acquisition of an adequate margin and making
chest wall resection necessary. (4) At the time of preoperative
planning, artifacts on MRI caused by respiratory movement
and beating of the heart make grasping the extent of tumor
infiltration difficult (Figure 2C). All these characteristics
interfere with the establishment of the resection margin in
cases of wide resection. To achieve local control, an adequate
resection margin is indispensable, and therefore thoracotomy
associated with rib resection or flap transfer for extensive skin
defect may be required in such cases.
In conclusion, because the majority of soft tissue sar-
comas originating from the chest wall are superficial and their
resection is easily achieved, unplanned excision is frequently
performed. Due to the anatomic characteristics of the chest
wall, it is often difficult to achieve an adequate resection
margin in cases of wide resection, but to ensure local control,
FIGURE 1. A, Kaplan-Meier life table analysis of cumulative
survival of chest wall sarcoma patients. High-grade malig-
nancy was the main factor significantly affecting life progno-
sis (p  0.05). B, Kaplan-Meier life table analysis of cumulative
survival of chest wall sarcoma patients. Local recurrence was
the main factor significantly affecting life prognosis (p  0.05).
TABLE 2. Overall Survival Rates According to Clinical
Variables
Variable Category
No. of
Patients (n  44) 5-yr OSR% p
Gender Male 28 91.1 0.67
Female 16 85.5
Age (yr) 50 14 100 0.05
50 30 81.6
Tumor grade Low grade 21 100 0.05
High grade 23 77.4
Tumor
location
Anterior 25 91.2 0.89
Posterior 11 90.9
Lateral 8 66.7
Tumor size
(cm)
5 16 83.9 0.51
5 28 91.1
Unplanned
excision
Intact or
biopsy
12 91.7 0.93
Unplanned
excision
32 87.6
Surgical
margin
Marginal 6 83.3 0.45
Wide 38 89.7
Local
recurrence
Local
recurrence
5 77.4 0.05
No local
recurrence
39 100
OSR, overall survival rate.
Tsukushi et al. Journal of Thoracic Oncology • Volume 4, Number 7, July 2009
Copyright © 2009 by the International Association for the Study of Lung Cancer836
it is necessary to secure an adequate resection margin and
resort to a flap. Especially, in MFH, some cases show re-
peated recurrence, making therapy very difficult and mandat-
ing a well-planned biopsy and ensuring of a safe resection
margin at presentation. Moreover, the possible development
of a high-grade sarcoma must be recognized and a musculo-
skeletal oncologist consulted.
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FIGURE 2. A, Macroscopic appearance of a chest wall sar-
coma. Multiple surgical wounds and recurrent tumor are
found. B, Postoperative pathologic specimen of a chest wall
sarcoma. Subcutaneous and intramuscular tumor infiltration is
present. C, Magnetic resonance imaging (MRI) T1-weighted
image of a chest wall sarcoma. Infiltrative tumor and artifacts
on MRI caused by respiratory movement are noted.
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